John Shannon
Chief Operating Officer
COO
Analyst — Sales
CEO
Chairman
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer | $742,334 | $5,042,584 |
| 2024 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer | $629,193 | $3,827,109 |
| 2023 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer | $571,411 | $1,848,153 |
| 2022 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer | $549,433 | $1,530,218 |
| 2021 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | $527,500 | $1,728,640 |
| 2020 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | $473,658 | $1,436,428 |
Executive changes
Earnings-call appearances
-
Xeris Biopharma Holdings, Inc. Q1 FY2026 Earnings Call2026-05-07
Xeris Biopharma Holdings, Inc. (XERS)
-
Xeris Biopharma Holdings, Inc. Q4 FY2025 Earnings Call2026-03-02
Xeris Biopharma Holdings, Inc. (XERS)
-
Xeris Biopharma Holdings, Inc. Q3 FY2025 Earnings Call2025-11-06
Xeris Biopharma Holdings, Inc. (XERS)
-
Xeris Biopharma Holdings, Inc. Q2 FY2025 Earnings Call2025-08-07
Xeris Biopharma Holdings, Inc. (XERS)
-
Xeris Biopharma Holdings, Inc. Q1 FY2025 Earnings Call2025-05-08
Xeris Biopharma Holdings, Inc. (XERS)
-
Xeris Biopharma Holdings, Inc. Q4 FY2024 Earnings Call2025-01-10
Xeris Biopharma Holdings, Inc. (XERS)
-
Xeris Biopharma Holdings, Inc. Q3 FY2024 Earnings Call2024-11-08
Xeris Biopharma Holdings, Inc. (XERS)
-
Xeris Biopharma Holdings, Inc. Q2 FY2024 Earnings Call2024-08-08
Xeris Biopharma Holdings, Inc. (XERS)
-
Xeris Biopharma Holdings, Inc. Q1 FY2024 Earnings Call2024-05-09
Xeris Biopharma Holdings, Inc. (XERS)
-
Xeris Biopharma Holdings, Inc. Q3 FY2023 Earnings Call2023-11-09
Xeris Biopharma Holdings, Inc. (XERS)